logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Acute Postoperative Pain

    Medications for Acute Postoperative Pain

    FiltersReset Filters
    3 results
    • ketorolac tromethamine

      (Ketorolac Tromethamine)
      Nephron SC Inc.
      Usage: Ketorolac tromethamine is indicated for short-term (≤5 days) management of moderately severe acute pain, primarily in postoperative settings. It is initially administered intravenously or intramuscularly, with oral use allowed only for continuation. Total usage should not exceed 5 days due to potential adverse reactions.
    • ketorolac tromethamine

      (Ketorolac Tromethamine)
      Chartwell RX, LLC
      Usage: Ketorolac tromethamine tablets are indicated for the short-term management (≤ 5 days) of moderately severe acute pain requiring opioid-level analgesia, primarily in postoperative settings. They serve as continuation therapy after initial IV or IM administration. Use should be minimized to reduce the risk of adverse reactions.
    • ropivacaine hydrochloride

      (ROPIVACAINE HYDROCHLORIDE)
      SOLA Pharmaceuticals, LLC
      Usage: Ropivacaine Hydrochloride is indicated for local or regional anesthesia in surgery and acute pain management, including epidural blocks for surgeries such as cesarean sections, major nerve blocks, and local infiltration for postoperative or labor pain relief.